Concepedia

David Wullimann

DW

Statistics

Publications

15

Citations

3.2K

H-Index

14

Active since

2020

Affiliations

Karolinska University Hospital(Current)

Karolinska Institutet

Science for Life Laboratory

Umeå University

KTH Royal Institute of Technology

David Wullimann is an author at Karolinska University Hospital specializing in immunology, infectious diseases, and sars-cov-2 infection.

ORCID

Publications per year

2020–2024

15

Publications

15

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros et al. · Cell · 2020 · 2K citations · Full text

, , +15

Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 293 citations · Full text

, , +15

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

Peter Bergman, Ola Blennow, Lotta Hansson et al. · EBioMedicine · 2021 · 223 citations · Full text

, , +10

MAIT cell activation and dynamics associated with COVID-19 disease severity

Tiphaine Parrot, Jean‐Baptiste Gorin, Andrea Ponzetta et al. · Science Immunology · 2020 · 211 citations · Full text

, , +13

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity

Egle Kvedaraite, Laura Hertwig, Indranil Sinha et al. · Proceedings of the National Academy of Sciences · 2021 · 136 citations · Full text

, , +14

1–5 of 15